USA - NYSE:CO - KYG393421030 - Common Stock
The current stock price of CO is 2.9876 USD. In the past month the price increased by 34.58%. In the past year, price decreased by -35.19%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.1 | 96.44B | ||
| CI | THE CIGNA GROUP | 9.49 | 71.96B | ||
| LH | LABCORP HOLDINGS INC | 16.53 | 21.73B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.22 | 20.98B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 108.86 | 19.67B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.51B | ||
| DVA | DAVITA INC | 12.5 | 8.25B | ||
| HIMS | HIMS & HERS HEALTH INC | 62.26 | 7.60B | ||
| CHE | CHEMED CORP | 19.52 | 6.26B | ||
| RDNT | RADNET INC | 208.58 | 6.10B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 32.12 | 5.80B | ||
| OPCH | OPTION CARE HEALTH INC | 18.92 | 4.58B |
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. The company employs 1,202 full-time employees The company went IPO on 2009-11-19. The firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The firm provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. The company also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.
Global Cord Blood Corporation
48 Fl., Bank Of China Tower
HK
CEO: Ting Zheng
Employees: 1202
Phone: 85236058180.0
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. The company employs 1,202 full-time employees The company went IPO on 2009-11-19. The firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The firm provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. The company also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.
The current stock price of CO is 2.9876 USD. The price increased by 34.58% in the last trading session.
CO does not pay a dividend.
CO has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
CO stock is listed on the New York Stock Exchange, Inc. exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CO.
Global Cord Blood Corporation (CO) has a market capitalization of 400.08M USD. This makes CO a Small Cap stock.
ChartMill assigns a technical rating of 4 / 10 to CO. When comparing the yearly performance of all stocks, CO is a bad performer in the overall market: 68.4% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to CO. While CO has a great health rating, its profitability is only average at the moment.
Over the last trailing twelve months CO reported a non-GAAP Earnings per Share(EPS) of 0.58. The EPS decreased by -1.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 40.3% | ||
| ROA | 5.87% | ||
| ROE | 10.27% | ||
| Debt/Equity | 0 |